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Introduction: Biologic grafts have been shown to support tissue regeneration in various animal models. Very few
reports in the literature exist to show tissue remodeling in patients after placement of a biologic graft.
Case presentation: We report the case of a 69-year-old Caucasian man with a history of small bowel carcinoid
resection and concurrent recurrent ventral hernia repair with component separation and underlay biologic graft
placement who underwent re-operation for metastatic carcinoid tumor to his liver. Complete incorporation of the
biologic graft was observed. Tissue analysis of the incised midline fascia revealed tissue remodeling at the site of
the previous abdominal wall defect.
Conclusion: Placement of a biologic graft in ventral hernia repair supports tissue regeneration similar to that
previously reported in animal models.
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The use of biologic graft materials in complex abdom-
inal wall reconstruction over the last several decades has
significantly increased, especially in contaminated cases
where synthetic mesh is relatively contraindicated. Two
important potential complications after complex abdom-
inal wall reconstruction are recurrence and infection.
Several studies have shown that although recurrence
rates are slightly lower in patients who have received
synthetic mesh than in those who have received biologic
graft material, the complication rates, especially the inci-
dence of infection, are higher [1]. The morbidity associ-
ated with an infected synthetic mesh is greater than an
infected biologic graft because management of an in-
fected synthetic mesh requires antibiotics and removal
of the foreign material, whereas infection of a biologic
graft can be managed with antibiotics and wound care
and does not typically require graft removal [2].
A recent study evaluating biologic graft biopsies ob-
tained during re-exploration for ventral hernia recur-
rence revealed that the duration of time the biologic
graft had been implanted was directly correlated with
the degree of constructive remodeling. The human der-
mis scaffolds that had been implanted longer showed* Correspondence: hsuehec@slu.edu
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capsulation, increased extracellular matrix deposition
and neovascularization, increased cellular penetration to
the center of the biopsy, and nearly complete scaffold
degradation [3].
Animal studies utilizing either porcine or human acel-
lular dermal matrices showed that after several weeks,
the tensile strength measurements of the abdominal wall
at the biologic graft-to-musculofascia interface were not
less, and in some cases were greater, than the adjacent
unwounded fascia [4-6]. In addition, histological and im-
munohistochemical analysis demonstrated remodeling
into fascia-like tissue with gene expression that was
similar to the native fascia. For example, the surface of
the biologic graft placed apposite to the bowel exhibited
cellularity consistent with peritoneum and collagen fiber
architecture similar to the alignment of native fascia
[4-6]. This suggests an active regenerative process that
allows for restoration of abdominal wall function. Des-
pite the increasing popularity of biologic grafts in hernia
repair, long-term histological evidence of biologic graft
incorporation in humans is scarce as healed surgical
sites are rarely revisited.Case presentation
A 69-year-old Caucasian man presented with recurrent
metastatic carcinoid tumor to his liver. His past surgical
history included gunshot wounds to his abdomen, resultingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ventral hernia developed that was repaired primarily. His
hernia recurred another 5 years later and was repaired
with a polypropylene mesh.
In 2009, he developed gastrointestinal symptoms of
intermittent bloating, epigastric pain, abdominal cramps,
and alternating episodes of diarrhea and constipation.
With increased frequency and severity of symptoms, he
subsequently developed a third recurrence of his ventral
hernia in late 2010. A small bowel mass was visualized
on a computed tomography scan in 2011 along with the
recurrent ventral hernia (Figure 1A-D). This prompted
serologic testing and radionuclide scanning studies that
lead to a diagnosis of carcinoid tumor. An octreotide
scan revealed uptake in his distal small bowel as well as
the dome of his liver suspicious for metastatic carcinoid
tumor with involvement of his liver.
He underwent exploratory laparotomy for the meta-
static carcinoid tumor in March 2011. A 5cm right flank
ventral hernia located at the edge of the polypropylene
mesh was found. Extensive adhesiolysis, small bowel
resection with primary anastomosis, cholecystectomy,




Figure 1 Cross-sectional computed tomography images of patient pr
Presence of synthetic mesh is also shown. B-D. Additional caudad images dem
seroma, and hernia recurrence due to separation of native fascia and mesh insegment 8 liver lesion (pathology positive for metastatic
neuroendocrine carcinoma), and a ventral hernia repair
were performed.
During the ventral hernia repair, the previously placed
polypropylene mesh was removed. The hernia sac was
excised and component separation consisting of a bilat-
eral rectus abdominis muscle advancement flap was
performed. His abdominal wall was reinforced with a
20cm×20cm non-cross-linked biologic hernia repair
graft underlay (Biodesign®, Cook Medical, Bloomington,
IN, USA) and secured with transfascial O Ethibond su-
tures (Ethicon, Blue Ash, OH, USA). The fascia edges
were approximated primarily over the biologic graft
with #1 polydioxanone (PDS) and drains were placed
in the subcutaneous layers. He recovered uneventfully.
Thirty months after the carcinoid resection and liver
tumor ablation, a repeat surveillance octreotide scan re-
vealed a suspicious 1.9cm lesion on segment 1 of his
liver that was confirmed with magnetic resonance im-
aging. Good fascial approximation at the site of the prior
recurrent ventral hernia repair was also noted (Figure 2).
He underwent surgery for recurrent metastatic carcinoid
tumor ablation in October 2013. On visual inspection,e-biologic graft placement. A. Arrow indicates the carcinoid tumor.





Figure 2 Cross-sectional magnetic resonance images of patient 30 months after biologic graft placement. A. Arrow indicates the
recurrent carcinoid tumor in the liver. B-D. Additional caudad images demonstrating abdominal wall integrity.
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biologic graft except for the presence of the permanent
transfascial Ethibond sutures (Figure 3). His native fascia
was observed. Tissue biopsies of the incised midline
fascia were obtained. Histology of the resected section
revealed vascularized dense connective tissue (Figure 4).Figure 3 Intraoperative photo of fascia where underlay biologic
graft was placed. Intraoperative photo of fascia in the region of
previously placed biologic graft with previously placed transfascial O
Ethibond sutures (arrows). There was no visual evidence of graft material.Discussion
Abdominal wall reconstruction with synthetic mesh or
biologic graft reinforcement has reduced hernia recur-
rence as compared to primary repair. Mesh positioning
can include onlay, underlay, interposition, or retrorectus
placement. Underlay or retrorectus placement has been
associated with lower recurrence rates [7].
Polyester, polypropylene, and polytetrafluoroethylene
(PTFE) are several types of materials used in pros-
thetic mesh. The mechanism by which prosthetic mesh
strengthens hernia repair is by inciting an intense in-
flammatory response to the foreign body with resultant
development of a strong scar plate. The inflammatory
changes around the alloplastic material used in abdom-
inal wall defect repair can persist for many years [8].
This intense inflammatory response and subsequent
scar plate formation can contribute to increased stiff-
ness of the abdominal wall and shrinkage of the mesh.
The use of “lightweight” mesh to decrease this inflam-
matory response has resulted in improved abdominal
wall compliance and less mesh shrinkage [9]. In a
clean abdomen without bacterial contamination, pros-
thetic mesh repair remains the standard of care for op-
timal long-term results.
AB
Figure 4 Histology analysis of midline fascia edge sampling.
Vascularized dense connective tissue at previously placed biologic
graft site. Blue ink indicates peritoneal edge of the fascia. A. 100×
magnification. B. 200× magnification.
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a decellularized collagen matrix derived from either por-
cine, bovine or human sources. Typically obtained from
either dermal or non-dermal sources these graft mate-
rials have undergone significant processing to remove
the cells and antigenic components, resulting in a highly
purified collagen architecture and surrounding extracellu-
lar matrix. Depending on the graft, the resulting product
may or may not be cross-linked [10]. The theory behind
the use of biologic grafts is that they provide scaffolding
for cells and new blood vessels to infiltrate, support tissue
regeneration, and can be used in the face of infection
where synthetic materials are relatively contraindicated.
Common hernia mesh implant complications include
recurrence, infection, seroma formation, integumentary
necrosis, chronically draining sinuses, enterocutaneous
fistulas, and intestinal obstruction [11]. Both classical
synthetic mesh materials and the more modern acellularbiologic graft materials may lead to post-hernia repair
complications. In particular, a review of the literature
has shown that postoperative complications involving
synthetic meshes are more likely to lead to mesh extru-
sion and extended comorbid complications, such as a
chronic inflammatory response resulting in chronic pain,
sensation of feeling the mesh, and stiffness of the ab-
dominal wall with loss of compliance [12]. These com-
plications can necessitate removal of the mesh to fully
resolve. However, complications involving many of the
biologic graft implants, such as infection, are treated
more conservatively [13].
Although a retrospective study assessing single-stage
ventral hernia repairs with lightweight polypropylene
mesh implants in clean-contaminated and contaminated
cases has shown some favorable results, re-operation
was 12% and the incidence of surgical site occurrences
(surgical site infection, wound dehiscence, or wound
breakdown) was 30% [14]. A systematic review of several
retrospective studies utilizing biologic grafts showed an
overall recurrence rate of 13.8%, which increased to
23.1% in contaminated/dirty repairs [15]. Biologic tissue
matrices are commonly used in contaminated or in-
fected surgical fields for one-stage repair with little to no
subsequent graft removal, but hernia recurrence over a
5-year period may be greater than 50% [16]. Therefore,
the durability of biologic grafts for single-stage repair in
contaminated settings needs further evaluation [17]. Fur-
ther prospective, randomized trials need to be conducted
before practice guidelines are established.
Animal studies of various biologic graft materials on
physicomechanical properties [18], immunological re-
sponses [19], neovascularization and collagen formation
[20], and other correlates of tissue repair have been
widely reported. The purported mechanism of hernia
defect repair with biologic grafts is by integration of the
biologic graft as a scaffold for tissue remodeling via neo-
vascularization and tissue regeneration. However, histo-
logic evidence of tissue remodeling after biologic graft
placement is lacking in humans, as few patients undergo
postoperative tissue analysis to verify the degree of graft
incorporation. To demonstrate clinically the claim of tis-
sue remodeling and graft incorporation as suggested by
the animal data would require serial biopsies over time
and would not be ethically feasible in any patient recover-
ing uneventfully from complex hernia repair. The current
case provides clinical evidence that long-term abdominal
wall integrity was achieved in a patient with a third recur-
rence of ventral hernia following component separation
repair using a biologic graft as a temporary scaffold.
Conclusions
Several animal studies have shown that biologic grafts in-
duce the expression of extracellular matrix components,
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promote fibroblast infiltration and migration into the
matrices. Our current observation suggests that tissue re-
generation in humans may mirror that of the animal
model. Improved tissue regeneration with implantation of
biologic graft materials in animals may also be seen in
humans.
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